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Abstract 
Introduction: Studies on mortality due to parasitic diseases such as Chagas disease are useful to understand the epidemiology and to plan and 
guide control measures for these diseases. We analyzed mortality trends due to Chagas disease in Brazil and regions, between 1979 and 2009. 
Methodology: Mortality data (underlying cause of death) were obtained from the nationwide Mortality Information System (SIM) of the 
Ministry of Health. We calculated crude mortality rates and rates standardized by age, as well as proportional mortality. 
Results: In total, 27,560,043 deaths occurred in the study period. In 172,066 deaths, Chagas disease was mentioned as the underlying cause 
(proportional mortality: 0.62%). The mean crude and age-standardized mortality rates were 3.61 and 5.19 deaths/100,000 inhabitants/year, 
respectively. During the observation period, Chagas mortality declined significantly at the national level (R2=97%, p<0.001), with different 
patterns between regions. There was a significant reduction in mortality in the Central-West (R2=90%, p<0.001), Southeast (R2=98%, 
p<0.001) and South (R2=94%, p< 0.001), but in the North (R2=34%, p=0.001) and Northeast (R2=65%, p<0.001) regions mortality increased. 
Conclusions: Despite the overall decline in mortality due to Chagas disease in Brazil, it remains an important public health problem. After 
successful control of the primary vector Triatoma infestans, intervention measures must focus on improved access to health care and 
secondary prevention. The North and Northeast regions, where vectors other than T. infestans have a primary role, need special attention. 
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Introduction 
A century after its discovery, Chagas disease 
remains a neglected tropical disease in Latin America 
[1,2]. In addition, due to increased international 
migration, the disease is becoming an emerging 
disease, mainly in North America and Europe [3-5]. 
Approximately 15 million people are infected in Latin 
America [1,5,6], causing 14,000 deaths annually [4,7]. 
In Brazil, with significant reduction of vector and 
transfusional transmission, the number of new cases 
has been drastically reduced in recent years [8]. 
Recent studies estimate around two to three million 
infected people in Brazil, as compared to seven 
million in the 1960s [1,9,10]. There are six thousand 
fatal cases per year, representing about 43% of the 
total number of deaths from Chagas disease in Latin 
America [11,12]. 
Given the chronic nature of Chagas disease and 
increased life expectancy in Brazil, it can be assumed 
that, in the next decades, mortality figures due to the 
disease will remain at a high level. Here we present 
data on mortality caused by Chagas disease in Brazil 
and its geographical regions from 1979 to 2009. 
 
Methodology 
Study design and data sources 
We conducted a nationwide study using mortality 
data from the Mortality Information System of the 
Ministry of Health of Brazil (SIM - Sistema de 
Informação de Mortalidade; SIM/MS/DATASUS), 
freely accessible at 
http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/
obt10uf.def. We included all deaths that occurred in 
Brazil between 1979 and 2009, the period available in 
the database. SIM data are based on death certificates  
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(declaração de óbito – DO), consisting of a 
standardized form with demographic and clinical 
information (causes of death), completed by 
physicians. 
Chagas disease was identified according to the 
Ninth and Tenth Revision of the International 
Statistical Classification of Diseases and Related 
Health Problems (ICD), with the following codes: 086 
for the period 1979-1995 (ICD-9) and B57 for 1996-
2009 (ICD-10) [13,14]. 
Population data were obtained from the Brazilian 
Institute of Geography and Statistics (IBGE; 
http://www.ibge.gov.br), based on data from the 
National Population Censuses (1980, 1991 and 2000), 
the Population Count (1996), and population estimates 
for intercensus years. 
 
Data analysis 
We present the crude mortality rate and 
proportional mortality due to Chagas Disease by 
region of residence and year of occurrence of death. 
Mortality rates were calculated by dividing the number 
of deaths in each calendar year by the population, and 
presented per 100,000. Proportional mortality was 
calculated by dividing the number of deaths from 
Chagas disease by the total number of deaths, 
multiplied by 100. To avoid differences in age profile 
of the regions analyzed, which may influence the 
observed trends, mortality rates were standardized by 
age using the direct method, considering the Brazilian 
population of the year 2010 as standard. 
Trend analysis of indicators was performed by 
simple linear regression and correlation. To avoid 
autocorrelation between the terms of the regression 
equation, we used the artifice to centralize the variable 
year, transforming it into calendar year less 1994 
(observation year - 1994), as this was the midpoint of 
the series. 
Calculation of indicators and preparation of tables 
and figures was performed using Microsoft Excel 
spreadsheets (Microsoft Corporation; Redmond, 
Washington, USA). We used SPSS for Windows 
version 15.0 (Statistical Package for the Social 
Sciences; IBM, SPSS Corporation, Chicago, USA) for 
linear regression and scatterplots. 
 
Ethics 
This study was solely based on publicly available 
secondary anonymous data, with no possibility of 
identification of individuals; thus approval by an 
ethical review board was not necessary. 
 
Results 
In total, there were 27,560,043 deaths between 
1979 and 2009 in Brazil. Chagas disease was 
mentioned as the underlying cause of death in 172,066 
(0.62%) cases. The mean mortality rate in the period 
was 3.61/100 000 inhabitants/year. Most (57.1%) 
deaths occurred in the Southeast region (98,199), 
followed by the Central-West 22.3% (38,310), 
Northeast 13.4% (23,051), South 6.4% (10,916) and 
North regions 0.9% (1,530). Crude and standardized 
mortality rates and proportional mortality in Brazil and 
regions over the observation period are depicted in 
Table 1. The highest mortality was observed in the 
Central-West region. Standardized data showed a 
considerable increase of mortality, as compared to 
crude data. 
Trends of crude mortality rates, standardized 
mortality rates, and proportional mortality in Brazil 
and regions are presented in Figures 1-3. There was a 
significant decrease of both mortality rates (crude: R2 
= 97%; standardized: R2 = 98%) and proportional 
mortality (R2 = 97%) in the country (all p < 0.001; 
Table 2). Mortality in the Central-West peaked at 
21.73 (crude rate) and 43.53 (standardized rate) in the  
 
Table 1. Crude and standardized mortality rates (per 100,000 inhabitants) and proportional mortality due to Chagas disease in Brazil and 
regions, 1979-2009 
Region Deaths (n) Crude mortality rate Standardized mortality rate Proportional 
mortality (%) 
North 1,530 0.45 0.81 0.12 
Northeast 23,051 1.67 2.35 0.34 
Southeast 98,199 4.84 6.48 0.72 
South 10,916 1.55 2.09 0.25 
Central-West 38,310 12.26 23.33 2.54 
Brazil 172,066 3.61 5.19 0.62 
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Figure 1. Crude mortality rate due to Chagas disease in Brazil and regions, 1979-2009 
 
Figure 2. Standardized mortality rate due to Chagas disease in Brazil and regions, 1979-2009 
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year 1981. Similar to the pattern observed at the 
national level, rates in these regions, along with those 
in the South, decreased steadily during the study 
period (Figures 1-3; Table 2). The largest decrease 
was observed in the Central-West, with a linear annual 
decrease of 0.45 deaths per 100,000 inhabitants (Table 
2). In contrast, the North and Northeast regions 
showed a slight but statistically significant increasing 
trend of Chagas disease mortality rates and 
proportional mortality, with the exception of the 
standardized mortality rate in the Northeast, which 
showed stabilization (Table 2). 
 
Discussion 
The present study describes the magnitude and 
trends of mortality due to Chagas disease over a period 
of 31 years, on a nationwide level. The data show an 
overall decline of mortality due to Chagas disease, but 
also demonstrated different regional patterns. Highly 
endemic areas such as the Central West and Southeast 
showed a steady decline over the years, whereas in the 
North and Northeast, where incidence is known to be 
relatively low, mortality figures have been increasing 
or maintained at a stable level [15]. 
The disparities in mortality trends among regions 
reflect the effectiveness of national control measures 
and control policies, which focused mainly on vector 
transmission and blood transfusion. The program 
directed its efforts to the elimination of transmission 
by the primary vector, the kissing bug Triatoma 
infestans. This vector is not frequent in the North and 
Northeast regions [15-17]; thus these regions did not 
benefit considerably from vector control actions 
performed in the last decades, as other vectors not 
affected by the intervention measures, such as 
Triatoma brasiliensis and Triatoma pseudomaculata, 
prevail in those areas [16,18]. In the Northeast 
region with the exception of Bahia state (an endemic 
area for T. infestans in the past), T. brasiliensis and T. 
pseudomaculata are native species with a center of 
endemism in the northeastern savannah region [16,17]. 
Interruption of transmission of Chagas disease by T. 
infestans had little effect on vector transmission in 
most states in the Northeast (Maranhão, Ceará, Rio 
Grande do Norte, Alagoas and Sergipe states) and 
other regions (Espírito Santo and Santa Catarina 
states). It can be assumed that Chagas mortality will 
remain a public health problem for decades in these 
regions [18,19], and control actions must be performed 
to reduce transmission by vectors other than T. 
infestans. 
In the Amazon region the majority of new cases of 
Chagas disease is mainly caused by oral route of 
transmission, through the consumption of natural 
products such as the palm products açaí juice, juçara 
juice and bacaba [1,20,21]. This mode of transmission 
and emerging public health concerns for safe foods 
encourage surveillance activities aimed at pasteurizing 
Figure 3. Proportional mortality due to Chagas disease in Brazil and regions, 1979-2009 
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the products and controlling the export of untreated 
juice and other products to other regions and out of the  
 
country [20]. However, mortality due to acute form of 
the disease, which occurs most commonly after oral 
infection, does not play a significant role, with 
nationwide and Amazon region Chagas deaths due to 
acute disease reported at 2.8% and 11%, respectively 
[12]. 
In addition to factors related to the control of 
vector transmission, the explanation for regional 
differences of mortality due to Chagas disease may 
also be related to different rates of migration between 
high and low endemic regions and unequal recognition 
of the disease as a public health threat by health 
professionals of these regions [22]. There are also 
remarkable regional differences in terms of access to 
diagnosis and treatment, the quality of care provided, 
diagnostic capacity, and quality of data [23]. Besides 
the control of vector and transfusional transmission of 
Chagas disease, it is assumed that the improved 
survival of patients resulting from better quality of 
health care may have contributed to the downward 
trend in mortality observed in the Central-West, 
Southeast and South [10]. The improved coverage of 
serological screening of blood donors substantially 
reduced the rates of transmission by transfusion in 
Brazil [24]. In addition, other transmission routes 
dependent on the enzootic cycle of transmission are 
also important, such as extra domiciliary vector 
transmission [8,25,26]. 
Mother-to-child transmission plays only a minor 
role in the country, except in the state of Rio Grande 
do Sul, which has the highest rates of mother-to-child 
transmission, as indicated by the data collected in a 
recent survey of seroprevalence in children under five 
years of age [26]. However, due to the absence of a 
systematic program of routine serological screening 
during prenatal care in endemic areas, and the fact that 
the majority of children with congenital transmission 
are clinically asymptomatic, it is difficult to estimate 
the actual prevalence of congenital Chagas disease in 
Brazil [27]. 
Table 2. Linear regression analysis on trends of mortality due to Chagas disease in Brazil and regions, 1979-2009 
Indicator Equation R
2
 p Trend 
Mortality rate     
Brazil     
Crude Y= 3.73 – 0.099x 0.97 <0.001 Descending 
Standardized Y= 5.19 – 0.185x 0.98 <0.001 Descending 
North     
Crude Y= 0.43 + 0.008x 0.34 0.001 Crescent 
Standardized Y= 0.81 + 0.013x 0.20 0.011 Crescent 
Northeast     
Crude Y= 1.68 + 0.014x  0.65 <0.001 Crescent 
Standardized Y= 2.35 + 0.003x 0.03 0.338 Stabilization 
Southeast     
Crude Y= 5.01 – 0.161x 0.98 <0.001 Descending 
Standardized Y= 6.48 – 0.269x 0.98 <0.001 Descending 
South     
Crude Y= 1.58 – 0.049x 0.94 <0.001 Descending 
Standardized Y= 2.09 – 0.087x 0.95 <0.001 Descending 
Central-West     
Crude Y= 12.94 – 0.450x 0.90 <0.001 Descending 
Standardized Y= 23.33 – 1.061x 0.93 <0.001 Descending 
Proportional mortality     
Brazil Y= 0.64 – 0.015x 0.98 <0.001 Descending 
North Y= 0.11 + 0.002x 0.33 0.001 Crescent 
Northeast Y= 0.33 + 0.004x  0.62 <0.001 Crescent 
Southeast Y= 0.74 – 0.021x 0.97 <0.001 Descending 
South Y= 0.26 – 0.008x 0.95 <0.001 Descending 
Central-West Y= 2.73 – 0.097x 0.97 <0.001 Descending 
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Chagas disease is emerging as an opportunistic 
disease, with reactivation of chronic disease in the 
form of meningoencephalitis and/or myocarditis, 
whether as an AIDS-defining condition or as an event 
that is associated with induced immunosuppression 
such as in transplants [27,29]. 
Aspects related to the focus of surveillance should 
be reviewed and must expand beyond acute cases. The 
increased survival of people with Chagas disease 
[2,30] will further increase the frequency of 
association with other chronic and degenerative 
diseases, with a need for comprehensive care of this 
population [31,32]. Control measures must go beyond 
classical actions such as vector control and serological 
screening of blood donors and should include 
comprehensive secondary prevention to avoid serious 
complications as well as social and financial costs 
[12]. Additionally, the unfavorable figures in the 
North and Northeast clearly indicate the need for a 
new approach in epidemiological surveillance of 
Chagas disease. 
It is known that mortality rates related to Chagas 
disease are strongly influenced by the unequal 
distribution of deaths and by possible differences in 
age structures of populations in regions of Brazil. In 
this study, in addition to the crude mortality rates, we 
also present age-standardized rates. Regional 
differences caused by different age distribution can 
thus be reduced. Standardized rates were remarkably 
higher than crude rates, but these estimates should 
only be used for comparative analysis, as the crude 
rates represent the actual values. 
The interpretation of mortality data over a period 
of more than 30 years on a nationwide context should 
take into consideration some limitations [32]. In 
general, secondary data contain inconsistencies 
regarding quality of data [14,15]. Deaths may be 
underreported, and this error probably has changed 
over time and regions [14]. Interpretation of trend data 
and regional differences should consider these 
circumstances. In fact, despite progress over the study 
period in both SIM coverage and quality of 
information on causes of death, coverage varied 
among states and regions of the country, especially in 
the North and Northeast [33-36]. Diagnostic criteria of 
T. cruzi infection are standardized throughout the 
country, which reduces possible random variations of 
the differences in mortality between regions [37]. 
Diagnosis of chronic Chagas disease is made after 
consideration of the patient's history (including 
epidemiological risk factors) and clinical examination. 
The chronic phase of Chagas disease is routinely 
diagnosed by commercial serologic methods, such as 
enzyme-linked immunoassays (ELISA), indirect 
immunofluorescence antibody test (IFAT), 
radioimmunoassay precipitation assay (RIPA), and 
indirect hemagglutination with whole or semipurified 
extracts of the epimastigotes of T. cruzi. The diagnosis 
is based on two subsequent tests based on different 
antigens or techniques to increase accuracy. When 
results are discordant, a third assay may be used to 
confirm or refute the diagnosis, or repeat sampling 
may be required [37]. 
The first-line test to confirm diagnosis of acute-
phase disease is direct examination of blood, by 
microscopy of fresh preparations of anticoagulated 
blood. This diagnosis can be made by observation of 
the parasite in a blood smear by microscopic 
examination. Thick and thin blood smears are made 
and stained for visualization of parasites [20,37]. 
Until the 1960s, diagnosis of the chronic phase 
was based on parasitological methodologies 
(xenodiagnosis, inoculation in experimental animals, 
blood culture) and serological test complement 
fixation (specifically, the Machado and Guerreiro 
reaction, used in Brazil until 1995). Diagnostic 
methods improved between 1960 and 1975 as blood 
culture techniques advanced and continue to be 
employed until the present. Results are comparable to 
those of xenodiagnosis with the advantage of allowing 
the isolation of the parasite. Inoculation of 
experimental animals is no longer used as a diagnostic 
method due to operational difficulties, as well as its 
low sensitivity in the chronic phase. Other serological 
tests that may be implemented include the following: 
indirect hemagglutination test (IHA); indirect 
immunofluorescence test (which has high sensitivity 
and was used to test more than one million samples in 
Brazil in the national serological survey, and 
determined very accurately the prevalence of the 
disease); and ELISA immunoassay test. This second 
historical period in the evolution of the diagnosis 
witnessed the development of methods that form the 
basis of the diagnosis in only 15 years, the period of 
our study. The combination of serological methods for 
diagnosis of infection increased the sensitivity and 
specificity. In the third period, from 1976 to the 
present, molecular biological methods have improved, 
although have not yet been considered for 
implementation in routine diagnostics of health 
services in the country. These methods are available in 
reference research centers for Chagas disease. 
Despite being a disease associated with poverty 
and rural populations, the majority of deaths related to 
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Chagas disease occur in the state capitals [11,12]. This 
situation, combined with improvements in the quality 
of the SIM database in recent years [35], suggests it is 
unlikely that changes in coverage and the proportion 
of deaths from defined causes in SIM have affected the 
total number of deaths from Chagas disease as the 
underlying cause in the period. 
This study used data on mortality due to Chagas 
disease merely as the underlying cause of death. This 
factor has caused a considerable loss of information 
contained in death certificates and underestimated 
rates [12,14,19,38,39]. The use of multiple causes of 
death considers all causes and would give a more 
reliable estimate [40,41]. In fact, we have shown 
recently with data from 1999 to 2007 that the use of 
multiple causes of death increased Chagas mortality 
by 21% [11,12,19,42]. However, the Brazilian SIM 
mortality data set only included information on 
multiple causes after the year 1999; thus this 
information could not be used in the present analysis.  
Despite the limitations mentioned, the results of 
this study show internal consistency as well as 
consistency with existing knowledge about Chagas 
disease, and are highly representative, as all deaths 
from Chagas disease during the period 1979 to 2009 in 
Brazil were included. 
Currently the chronic cases of Chagas disease are 
not subject to compulsory notification in Brazil. For 
surveillance purposes, sample surveys are conducted 
which are both labor- and cost-intensive. To provide 
more information at low cost, mortality data can be 
used as an indicator of the epidemiological situation in 
an area of risk. These data may be more useful than 
morbidity data, because they often have greater 
completeness and validity. The present study 
exemplifies the use of this type of analysis to support 
the planning and evaluation of activities aimed at the 
monitoring and control of Chagas disease in Brazil. 
We conclude that control of Chagas disease 
remains a challenge for public health, and probably 
will remain so for many years. Serious attention and 
continued surveillance of the main mechanisms of 
transmission in endemic and emerging regions are 
needed. New control strategies for oral transmission 
(in the Amazon region) and secondary vectors such as 
T. brasiliensis and T. pseudomaculata (in the 
Northeast region) must be implemented and assessed 
systematically. In addition, adequate access to health 
services and social assistance should be guaranteed for 
the large number of individuals afflicted with chronic 
Chagas disease during the last decades. 
 
References 
1.  Coura JR and Dias JCP (2009) Epidemiology, control and 
surveillance of Chagas disease: 100 years after its Discovery. 
Mem Inst Oswaldo Cruz 104: 31-40. 
2.  Moncayo A and Silveira AC (2009) Current epidemiological 
trends for Chagas disease in Latin America and future 
challenges in epidemiology, surveillance and health policy. 
Mem Inst Oswaldo Cruz 104: 17-30. 
3.  Schmunis GA (2007) Epidemiology of Chagas disease in 
non-endemic countries: the role of international migration. 
Mem Inst Oswaldo Cruz 102: 75-85. 
4.  Coura JR and Viñas PA (2010) Chagas Disease: a new 
worldwide challenge. Nature 45: s6-7. 
5.  Schmunis GA and Yadon ZE (2010) Chagas Disease: a Latin 
American health problem becoming a world health problem. 
Acta Tropica 115: 14-21. 
6.  Word Health Organization (2002) Control of Chagas Disease 
(Technical Report Series 905). Geneva: Word Health 
Organization. 
7.  Word Health Organization (2010) Chagas Disease (American 
trypanosomiasis) fact sheet (revised in June 2010). Weekly 
Epidemiological Record 34: 334-336. Available: 
http://www.who.int/wer/2010/wer8534.pdf. 20 Accessed 
October 2010. 
8.  Silveira AC, Dias JCP (2011) O controle da transmissão 
vetorial. Rev Soc Bras Med Trop 44: 52-63. 
9.  Dias JCP (2011) Globalização, iniquidade e doença de 
Chagas. Cad Saúde Pública 23: 13-22. 
10.  Ramos Júnior NA and Carvalho DM (2009) Doença de 
Chagas: passado, presente e futuro. Cad Saúde Colet 17: 787-
794. 
11.  Martins-Melo FR (2011) Epidemiologia e distribuição 
especial da mortalidade relacionada à doença de Chagas no 
Brasil, 1999 a 2007. Dissertation (PhD) -Postgraduate 
Program in Public Health, Department of Community Health, 
School of Medicine, Federal University of Ceará, Fortaleza, 
Brazil. 
12.  Martins-Melo FR, Alencar CH, Ramos Jr NA, Heukelbach J 
(2012) Epidemiology of mortality related to Chagas Disease 
in Brazil, 1999-2007. PLoS NTD 6: e1508. 
13.  Word Health Organization (2007) International Statistical 
Classification of Diseases and Related Health Problems 
(ICD): 10th Revision. Version 2007:  Word Health 
Organization. Available: 
http://apps.who.int/classifications/apps/icd/icd10online/. 
Acessed 15 October 2010. 
14.  Santo AH (2009) Tendência da mortalidade relacionada à 
doença de Chagas, Estado de São Paulo, Brasil, 1985 a 2006: 
estudo usando causas múltiplas de morte. Rev Panam Salud 
Publica 26: 299-309. 
15.  Drumond JAG, and Marcopito LF (2006) Migração interna e 
a distribuição da mortalidade por doença de Chagas, Brasil, 
1981/1998. Cad Saúde Pública 22: 2131-2140. 
16. Ramos Jr AN, and Carvalho DM (2001) Os diferentes 
significados da certificação conferida ao Brasil como estando 
livre da doença de Chagas. Cad Saúde Pública 17: 1403-1412. 
17.  Silveira AC (2011) O Inquérito triatomínico (1975-1983). 
Rev Soc Bras Med Trop 44: 26-32. 
18.  Braz SCM, Melo MFAD, Lorena VMB, Souza WV, Gomes 
YM (2011) Chagas disease in the State of Pernambuco, 
Brazil: analysis of admissions and mortality time series. Rev 
Soc Bras Med Trop 44: 318-323. 
Martins-Melo et al. – Chagas disease in Brazil                             J Infect Dev Ctries 2012; 6(11):817-824. 
824 
19.  Martins-Melo FR, Ramos Jr AN, Alencar CH, Heukelbach J 
(2012) Mortality related to Chagas disease and HIV/AIDS 
coinfection in Brazil. J Trop Med 2012: 534649. 
20. Pan American Health Organization (2009) Guia para 
vigilância, prevenção, controle e manejo clínico da doença de 
Chagas aguda transmitida por alimentos. Rio de Janeiro: 
PANAFTOSA-VP/PAHO/WHO. 
21.  Silveira AC (2011) Os novos desafios e perspectivas futuras 
do controle. Rev Soc Bras Med Trop 44 Suppl 2: 22-124. 
22.  Litvoc J, Wanderley DMV, Camargo LMA (1992) 
Mortalidade por doença de Chagas no Estado de São Paulo 
(Brasil): subsídios para o planejamento da assistência ao 
chagásico. Rev Saúde Pública 26: 59-65. 
23.  Cervi A, Hermsdorff HHM, Ribeiro RCL (2005) Tendência 
da mortalidade por doenças neoplásicas em 10 capitais 
brasileiras, de 1980 a 2000. Rev Bras Epidemiol 8: 407-418. 
24.  Dias JCP and Amato Neto V (2011) Prevenção referente às 
modalidades alternativas de transmissão do Trypanosoma 
cruzi no brasil. Rev Soc Bras Med Trop 44 Suppl 2: 68-72. 
25.  Silveira AC, Dias JCP (2011) O controle da transmissão 
vetorial. Rev Soc Bras Med Trop 44 Suppl 2: 52-63. 
26.  Ostermayer AL, Passos ADC, Silveira AC, Ferreira AW, 
Macedo V, Prata AR (2011) O inquérito nacional de 
soroprevalência de avaliação do controle da doença de Chagas 
no Brasil (2001-2008). Rev Soc Bras Med Trop 44 Suppl 2: 
108-121. 
27.  Dias JCP, Amato Neto V, Luna EJA (2011) Mecanismos 
alternativos de transmissão do Trypanosoma cruzi no Brasil e 
sugestões para sua prevenção. Rev Soc Bras Med Trop 44: 
375-379. 
28.  Martins-Melo FR, Ramos Jr AN, Alencar CH, Lange W, 
Heukelbach J (2012) Mortality of Chagas’ disease in Brazil: 
spatial patterns and definition of high-risk areas. Trop Med Int 
Health 17: 1066-1075. 
29.  Ramos Jr AN, Correa D, Almeida EA, Shikanai-Yasuda MA 
(2010) History, current issues and future of the Brazilian 
network for attending and studying Trypanosoma cruzi/HIV 
coinfection. J Infect Dev Ctries 4: 682-688. 
30.  Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, 
Brutus L, Pialoux G (2010) Chagas disease: changes in 
knowledge and management. Lancet Infect Dis 10: 556-570. 
31. Alves RMA, Thomaz RP, Almeida EA, Wanderley JS, 
Guariento ME (2009) Chagas Disease and ageing: the 
coexistence of other chronic diseases with Chagas Disease in 
elderly patients. Rev Soc Bras Med Trop 42: 622-628. 
32.  Guariento ME, Carrijo CM, Almeida EA, Magna LA (2011) 
Perfil clínico de idosos portadores de doença de Chagas 
atendidos em serviço de referência. Rev Bras Clin Med 9: 20-
24. 
33.  França E, Abreu DX, Rao C, Lopez AD (2008) Evaluation of 
cause-of-death statistics for Brazil, 2002-2004. Int J 
Epidemiol 37: 891-901. 
34.  Mameri CP (1990) Tendências populacionais: óbitos por 
causas mal definidas. Conjuntura Demográfica 10: 7-10. 
35.  Mello Jorge MHP, Laurenti R, Gotlieb SLD (2007) Análise 
da qualidade das estatísticas vitais brasileiras: a experiência 
de implantação do SIM e do SINASC. Ciênc Saúde Coletiva 
12: 643-654. 
36.  Santo AH (2008) Causas mal definidas de morte e óbitos sem 
assistência. Rev Assoc Med Bras 54: 23-28. 
37.  Ministério da Saúde (2005) Consenso Brasileiro em Doença 
de Chagas. Rev Soc Bras Med Trop 38 Suppl 3: 1-29. 
38.  Rezende EM, Sampaio IBM, Ishitani LH, Martins EF, Vilella 
LCM (2010) Mortalidade de idosos com desnutrição em Belo 
Horizonte, Minas Gerais, Brasil: uma análise 
multidimensional sob o enfoque de causas múltiplas de morte. 
Cad Saúde Pública 26: 1109-1121. 
39.  Goldacre MJ, Duncan ME, Cook-Mozaffari P, Griffith M 
(2003) Trends in mortality rates comparing underlying-cause 
and multiple-cause coding in an English population 1979-
1998. J Public Health Med 25: 249-253. 
40.  Laurenti R (1974) A análise da mortalidade por causa básica e 
por causas múltiplas. Rev Saúde Pública 8: 421-435. 
41. Laurenti R and Buchalla CM (2000) A elaboração de 
estatísticas de mortalidade segundo causas múltiplas. Rev 
Bras Epidemiol 3: 21-28. 
42.  Martins-Melo FR, Ramos Jr AN, Alencar CH, Heukelbach J 
(2012). Multiple causes of death related to Chagas' disease in 
Brazil, 1999 to 2007. Rev Soc Bras Med Trop 45: 591-596. 
 
Corresponding author 
Professor Jorg Heukelbach, MD PhD 
Department of Community Health 
School of Medicine 
Federal University of Ceará 
Rua Professor Costa Mendes, 1608, 5. andar 
Fortaleza CE 60430-140, Brazil 
Tel: +55 85 3366-8045 
Email: heukelbach@web.de 
 
Conflict of interests: No conflict of interests is declared.
 
 
 
